Metadata

Name CCU002_02 COVID19 vaccination
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources




Clinical Terminologies SNOMED-CT
Codelists covid_impact_ccu00202_COVID19_vaccine_AstraZeneca_England_SNOMEDCT.csv covid_impact_ccu00202_COVID19_vaccine_dose_England_SNOMEDCT.csv covid_impact_ccu00202_COVID19vaccine_Moderna_England_SNOMEDCT.csv covid_impact_ccu00202_COVID19vaccine_Pfizer_England_SNOMEDCT.csv
Valid Event Data Range 08/12/2020 - 18/03/2021
Sex Female
Male
Authors CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow
Agreement Date 23 Aug 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

Code type is set to 1 for incident events, and 0 for prevalent events.

England primary care EHR: COVID19 vaccine: AstraZeneca

terminology code term code_type
SNOMEDCT 39114911000001105 COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 8 dose (product)
SNOMEDCT 39114911000001105 COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) 10 dose (product)
SNOMEDCT 39114911000001105 COVID-19 Vaccine AstraZeneca (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca UK Ltd) (product)

England primary care EHR: COVID19 vaccine: dose

terminology code term code_type
SNOMEDCT 1324691000000104 Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)
SNOMEDCT 1324681000000101 Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (procedure)

England primary care EHR: COVID19vaccine: Moderna

terminology code term code_type
SNOMEDCT 39326911000001101 COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) (product)
SNOMEDCT 39375411000001104 COVID-19 mRNA (nucleoside modified) Vaccine Moderna 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) 10 dose (product)

England primary care EHR: COVID19vaccine: Pfizer

terminology code term code_type
SNOMEDCT 39115611000001103 COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) (product)
SNOMEDCT 39114911000001105 COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) 6 dose (product)

Publication

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England

CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow

medRxiv 2021.08.18.21262222; doi: https://doi.org/10.1101/2021.08.18.21262222